Physician profile
Meredith Magee
NPI 1275277220
$328.50
in general payments reported to CMS, 2019-2025
11 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $73.37 | 2025 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $45.79 | 2025 | |
| Exact Sciences Corporation | $44.31 | 2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $35.50 | 2025 | Rexulti |
| Pfizer INC. | $31.44 | 2025 | |
| Dexcom, INC. | $20.50 | 2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $18.48 | 2025 | Korlym |
| Janssen Pharmaceuticals, INC | $17.15 | 2025 | Spravato |
| Lilly USA, LLC | $14.17 | 2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $14.04 | 2025 | Ozempic |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.75 | 2025 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Magee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.